VBLT - VBL Therapeutics to Report First Quarter 2020 Financial Results on May 14
TEL AVIV, Israel, May 04, 2020 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for cancer, today announced that it will host a conference call and live audio webcast on Thursday, May 14, 2020 at 8:30am Eastern Time to report first quarter ended March 31, 2020 financial results and to provide a corporate update.
| Thursday May 14th @ 8:30amET |
| From the US: |
| 877-407-9208 |
| International: |
| 201-493-6784 |
| Israel: |
| 1 809 406 247 |
| Conference ID: |
| 13703295 |
| Webcast: |
| https://edge.media-server.com/mmc/p/ubiyng5a |
About VBL
Vascular Biogenics Ltd., operating as VBL Therapeutics, is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class treatments for areas of unmet need in cancer and immune/inflammatory indications.
INVESTOR CONTACT:
Michael Rice
LifeSci Advisors, LLC
(646) 597-6979